Vaccine and treatment evaluation units (vteu) overall administration, clinical operations support and concept and protocol development, implementation and assays task area a-d task order…
Ended Awarded Last action
- Contract number
- 75N93018F00024
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,072,783
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (vteu) Award Notice · Posted Mar 29, 2012
- Contract value 23% obligated
-
- $1,072,782.89 Current, with exercised options
- $4,606,034.89 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Atlanta, GA 30322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | -$156,842 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $658,984 | |
| Exercise an Option | $62,850 | |
| Original award | $507,791 |
About this award
This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases.
The Delivery Order, with a ceiling value of $4,606,034.89, covers overall administration, clinical operations support, and the development, implementation and assays for vaccine and treatment concepts and protocols. The contract has an ultimate completion date of August 31, 2024. Emory University is the prime contractor, and there is no set-aside designation for this award.
Emory University is a major recipient of federal research funding, particularly from NIH, and has an extensive track record in conducting clinical trials, developing diagnostic tools, and performing advanced biomedical research related to infectious diseases, public health, and other areas. This contract award further bolsters Emory's role as a key partner for the federal government in advancing medical countermeasures against infectious diseases.
Description
Vaccine and treatment evaluation units (vteu) overall administration, clinical operations support and concept and protocol development, implementation and assays task area a-d task order FY.2019.A1B1C1D1.0103
Quick answers
Who was awarded contract 75N93018F00024?
75N93018F00024 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 19, 2018.
How much is contract 75N93018F00024 worth?
The government has obligated $1,072,783 on 75N93018F00024. Its potential value, with all options, is $4,606,035.
Is contract 75N93018F00024 an order under another contract?
Yes. 75N93018F00024 is a delivery order under HHSN272201300018I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract 75N93018F00024 competed?
The extent of competition for 75N93018F00024 was full and open competition. The government received 9 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award